Subcutaneous Epcoritamab in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma: Preliminary Phase 1/2 Results

被引：0

作者：

Linton, Kim M. ^{[1
,2
]}

Wahlin, Bjorn ^{[3
,4
]}

Leppa, Sirpa ^{[5
]}

Morschhauser, Franck ^{[6
]}

Elliott, Brian ^{[7
]}

Liu, Tracy ^{[7
]}

Stirner, Mariana Cota ^{[8
]}

Abbas, Aqeel ^{[7
]}

Falchi, Lorenzo ^{[9
]}

机构：

[1] Christie NHS Fdn Trust, Manchester, Lancs, England

[2] Manchester Canc Res Ctr, Manchester, Lancs, England

[3] Karolinska Inst, Stockholm, Sweden

[4] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland

[5] Univ Helsinki, Helsinki, Finland

[6] Univ Lille, CHU Lille, Lille, France

[7] Genmab, Princeton, NJ USA

[8] AbbVie, N Chicago, IL 60064 USA

[9] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, New York, NY USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 197卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH22-PO53

引用

页码：94 / 94

页数：1

共 50 条

[31] R2: Preliminary Results of a Phase II Study of Lenalidomide and Rituximab in Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (NHL) [J].

DeRook, Ian ;

Odonnell, Robert T. ;

Noble, B. ;

Quirch, C. ;

Tuscano, Joseph .

BLOOD, 2008, 112 (11) :1052-1052

[32] Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial [J].

Zinzani, Pier Luigi ;

Pellegrini, Cinzia ;

Gandolfi, Letizia ;

Stefoni, Vittorio ;

Quirini, Federica ;

Derenzini, Enrico ;

Broccoli, Alessandro ;

Argnani, Lisa ;

Pileri, Stefano ;

Baccarani, Michele .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) :462-466

[33] Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study [J].

Thieblemont, Catherine ;

Phillips, Tycel ;

Ghesquieres, Herve ;

Cheah, Chan Y. ;

Clausen, Michael Roost ;

Cunningham, David ;

Do, Young Rok ;

Feldman, Tatyana ;

Gasiorowski, Robin ;

Jurczak, Wojciech ;

Kim, Tae Min ;

Lewis, David John ;

van der Poel, Marjolein ;

Poon, Michelle Limei ;

Doerr, Thomas ;

Kilavuz, Nurgul ;

Chen, Menghui ;

Sacchi, Mariana ;

Elliott, Brian ;

Hutchings, Martin ;

Lugtenburg, Pieternella .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S379-S379

[34] Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma [J].

Baiocchi, Robert A. ;

Alinari, Lapo ;

Lustberg, Mark E. ;

Lin, Thomas S. ;

Porcu, Pierluigi ;

Li, Xiaobai ;

Johnston, Jeffrey S. ;

Byrd, John C. ;

Blum, Kristie A. .

CANCER, 2011, 117 (11) :2442-2451

[35] Phase II trial of combination of bortezomib and rituximab in relapsed and/or refractory Waldenstrom Macroglobulinemia: Preliminary results [J].

Ghobrial, Irene M. ;

Padmanabhan, Swaminathan ;

Badros, Ashraf ;

Nelson, Marybeth ;

Leduc, Renee ;

Leleu, Xavier ;

Warren, Diane ;

Soumerai, Jacob ;

Birner, Ann ;

Schlossman, Robert ;

Munshi, Nikhil ;

Richardson, Paul ;

Treon, Steven P. ;

Anderson, Kenneth C. .

BLOOD, 2007, 110 (11) :195B-195B

[36] A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma [J].

Reid W. Merryman ;

Robert A. Redd ;

Arnold S. Freedman ;

Inhye E. Ahn ;

Jennifer R. Brown ;

Jennifer L. Crombie ;

Matthew S. Davids ;

David C. Fisher ;

Eric D. Jacobsen ;

Austin I. Kim ;

Ann S. LaCasce ;

Samuel Ng ;

Oreofe O. Odejide ;

Erin M. Parry ;

Iris Isufi ;

Justin Kline ;

Jonathon B. Cohen ;

Neha Mehta-Shah ;

Nancy L. Bartlett ;

Matthew Mei ;

Thomas M. Kuntz ;

Jacquelyn Wolff ;

Scott J. Rodig ;

Philippe Armand ;

Caron A. Jacobson .

Annals of Hematology, 2024, 103 :185-198

[37] Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma [J].

Merryman, Reid W. ;

Redd, Robert A. ;

Freedman, Arnold S. ;

Ahn, Inhye E. ;

Brown, Jennifer R. ;

Crombie, Jennifer L. ;

Davids, Matthew S. ;

Fisher, David C. ;

Jacobsen, Eric D. ;

Kim, Austin, I ;

LaCasce, Ann S. ;

Ng, Samuel ;

Odejide, Oreofe O. ;

Parry, Erin Michelle ;

Isufi, Iris ;

Kline, Justin ;

Cohen, Jonathon B. ;

Mehta-Shah, Neha ;

Bartlett, Nancy L. ;

Mei, Matthew ;

Armand, Philippe ;

Jacobson, Caron A. .

BLOOD, 2022, 140 :6531-6533

[38] A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma [J].

Merryman, Reid W. ;

Redd, Robert A. ;

Freedman, Arnold S. ;

Ahn, Inhye E. ;

Brown, Jennifer R. ;

Crombie, Jennifer L. ;

Davids, Matthew S. ;

Fisher, David C. ;

Jacobsen, Eric D. ;

Kim, Austin I. ;

LaCasce, Ann S. ;

Ng, Samuel ;

Odejide, Oreofe O. ;

Parry, Erin M. ;

Isufi, Iris ;

Kline, Justin ;

Cohen, Jonathon B. ;

Mehta-Shah, Neha ;

Bartlett, Nancy L. ;

Mei, Matthew ;

Kuntz, Thomas M. ;

Wolff, Jacquelyn ;

Rodig, Scott J. ;

Armand, Philippe ;

Jacobson, Caron A. .

ANNALS OF HEMATOLOGY, 2024, 103 (01) :185-198

[39] ANALYSIS OF A PHASE 2 STUDY OF LENALIDOMIDE AND RITUXIMAB IN RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA [J].

Dutia, M. ;

DeRoock, I. ;

Chee, K. ;

O'Donnell, R. ;

Quirch, C. ;

Reed-Pease, C. ;

Tuscano, J. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 :118-118

[40] inMIND: A Phase 3 Study of Tafasitamab Plus Lenalidomide and Rituximab Versus Placebo Plus Lenalidomide and Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL) [J].

Sehn, Laurie H. ;

Hubel, Kai ;

Luminari, Stefano ;

Salar, Antonio ;

Wahlin, Bjorn E. ;

Gopal, Ajay K. ;

Bonnet, Christophe ;

Paneesha, Shankara ;

Trneny, Marek ;

Mashegu, Hafsat ;

Lihou, Christine F. ;

Cheng, Lulu ;

Scholz, Christian W. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S385-S386

← 1 2 3 4 5 →